Therefore, T cells can retard immune response on the tumor by inhibiting the action of both tumor-specific (CD8+ cytotoxic T lymphocytes and CD4+ T helper cells) and tumor-unspecific effector cells such as natural killer (NK) and NK T cells. Here, CD8A is linked to neoplasm.